These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9359691)

  • 1. Dimers are a girl's best friend.
    Rowland-Jones S
    Nat Med; 1997 Nov; 3(11):1199-200. PubMed ID: 9359691
    [No Abstract]   [Full Text] [Related]  

  • 2. Low frequency of CCR5delta32 allele among Greeks in Cyprus.
    Christodoulou C; Poullikas M; Neumann AU; Kostrikis LG
    AIDS Res Hum Retroviruses; 1997 Nov; 13(16):1373-4. PubMed ID: 9359656
    [No Abstract]   [Full Text] [Related]  

  • 3. Protective role of beta-chemokines associated with HIV-specific Th responses against perinatal HIV transmission.
    Wasik TJ; Bratosiewicz J; Wierzbicki A; Whiteman VE; Rutstein RR; Starr SE; Douglas SD; Kaufman D; Sison AV; Polansky M; Lischner HW; Kozbor D
    J Immunol; 1999 Apr; 162(7):4355-64. PubMed ID: 10201969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against human immunodeficiency virus type 1 infection in persons with repeated exposure: evidence for T cell immunity in the absence of inherited CCR5 coreceptor defects.
    Goh WC; Markee J; Akridge RE; Meldorf M; Musey L; Karchmer T; Krone M; Collier A; Corey L; Emerman M; McElrath MJ
    J Infect Dis; 1999 Mar; 179(3):548-57. PubMed ID: 9952360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCR6 ligands inhibit HIV by inducing APOBEC3G.
    Lafferty MK; Sun L; DeMasi L; Lu W; Garzino-Demo A
    Blood; 2010 Feb; 115(8):1564-71. PubMed ID: 20023216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal immunity, HIV transmission, and AIDS.
    Miller CJ; McGhee JR; Gardner MB
    Lab Invest; 1993 Feb; 68(2):129-45. PubMed ID: 8441249
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemokine receptors CCR5 and CCR2 genes in HIV positive, HIV exposed seronegative and in HIV unexposed individuals: A study from Mumbai.
    Chaudhari DV; Kerkar SC; Chavan V; Mehta PR; Mania-Pramanik J
    Indian J Dermatol Venereol Leprol; 2015; 81(5):548. PubMed ID: 26087087
    [No Abstract]   [Full Text] [Related]  

  • 8. Cellular immunity and target cell susceptibility in persons with repeated HIV-1 exposure.
    Akridge R; Hladik F; Markee J; Alef C; Kelley H; Collier A; Collier A; McElrath MJ
    Immunol Lett; 1999 Mar; 66(1-3):15-9. PubMed ID: 10203029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human immunodeficiency virus (HIV) gag antigen-specific T-helper and granule-dependent CD8 T-cell activities in exposed but uninfected heterosexual partners of HIV type 1-infected individuals in North India.
    Pallikkuth S; Wanchu A; Bhatnagar A; Sachdeva RK; Sharma M
    Clin Vaccine Immunol; 2007 Sep; 14(9):1196-202. PubMed ID: 17823271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-mediated immune response to human immunodeficiency virus in homosexual men.
    Ranki A
    J Infect Dis; 1993 Feb; 167(2):498. PubMed ID: 8421190
    [No Abstract]   [Full Text] [Related]  

  • 11. T-helper cell responses among HIV-infected children in Soweto, South Africa.
    Meyers TM; Kuhn L; Meddows-Taylor S; Simmank K; Sherman GG; Tiemessen CT
    Ann N Y Acad Sci; 2000 Nov; 918():373-6. PubMed ID: 11131729
    [No Abstract]   [Full Text] [Related]  

  • 12. Mucosal approaches to HIV vaccine development.
    Forrest BD
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1523-5. PubMed ID: 1466996
    [No Abstract]   [Full Text] [Related]  

  • 13. The cellular immune response to the human immunodeficiency virus.
    Rivière Y
    Curr Opin Immunol; 1989-1990 Feb; 2(3):424-7. PubMed ID: 2576771
    [No Abstract]   [Full Text] [Related]  

  • 14. The coreceptor mutation CCR5Delta32 influences the dynamics of HIV epidemics and is selected for by HIV.
    Sullivan AD; Wigginton J; Kirschner D
    Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10214-9. PubMed ID: 11517319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can immune responses to human immunodeficiency virus be preserved, enhanced, or restored?
    Walker BD
    AIDS Clin Rev; 2000-2001; ():101-14. PubMed ID: 10999218
    [No Abstract]   [Full Text] [Related]  

  • 16. Lack of protection from HIV infection by the mutant HIV coreceptor CCR5 in intravenously HIV infected hemophilia patients.
    Malo A; Rommel F; Bogner J; Gruber R; Schramm W; Goebel FD; Riethmüller G; Wank R
    Immunobiology; 1998 Feb; 198(4):485-8. PubMed ID: 9562872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of CCR5-Δ32 against HIV infection by the heterosexual mode of transmission in a Polish population.
    Zwolińska K; Knysz B; Rybka K; Pazgan-Simon M; Gąsiorowski J; Sobczyński M; Gładysz A; Piasecki E
    AIDS Res Hum Retroviruses; 2013 Jan; 29(1):54-60. PubMed ID: 22957692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut Microbiome Homeostasis and the CD4 T- Follicular Helper Cell IgA Axis in Human Immunodeficiency Virus Infection.
    Onabajo OO; Mattapallil JJ
    Front Immunol; 2021; 12():657679. PubMed ID: 33815419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCR5 genotype and human immunodeficiency virus (HIV)-specific mucosal antibody in seronegative women at high risk for HIV infection.
    Williams SB; Flanigan TP; Artenstein AW; VanCott TC; Smith D; Mayer K; Koup RA
    J Infect Dis; 1999 May; 179(5):1310-2. PubMed ID: 10191415
    [No Abstract]   [Full Text] [Related]  

  • 20. Combined effect of CCR5-Delta32 heterozygosity and the CCR5 promoter polymorphism -2459 A/G on CCR5 expression and resistance to human immunodeficiency virus type 1 transmission.
    Hladik F; Liu H; Speelmon E; Livingston-Rosanoff D; Wilson S; Sakchalathorn P; Hwangbo Y; Greene B; Zhu T; McElrath MJ
    J Virol; 2005 Sep; 79(18):11677-84. PubMed ID: 16140745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.